Showing all 12 results

Show sidebar
Show 9 12 18 24
Compare

Lynparza (olaparib)

£4,329.56
Lynparza (olaparib) is a medication used for the treatment of ovarian, fallopian tube, primary peritoneal cancer, prostate cancer, prostate cancer and breast cancer.
Add to wishlist
Select options
Quick view
Compare

Ninlaro (ixazomib)

£5,150.00
Ninlaro (ixazomib) is a medication used for the treatment of multiple myeloma.
Add to wishlist
Select options
Quick view
Compare

Odomzo (sonidegib)

£4,542.90
Odomzo (sonidegib) is a medication for the treatment of locally advanced basal cell carcinoma (BCC) that cannot be treated with surgery or radiation therapy.
Add to wishlist
Select options
Quick view
Compare

Onivyde (irinotecan hydrochloride trihydrate)

£900.00
What is Onivyde (irinotecan) for? Onivyde (liposomal irinotecan) is indicated in combination with 5-fluorouracil and leucovorin (two other cancer medicines)
Add to wishlist
Select options
Quick view
Compare

Opdivo (Nivolumab)

£500.00 – £1,285.24
Opdivo (nivolumab) is a medication used for the treatment of certain types of cancer.
Add to wishlist
Select options
Quick view
Compare

Perjeta (Pertuzumab)

£2,400.00
Perjeta (pertuzumab) is a medication used for the treatment of HER2 positive breast cancer in patients with metastatic cancer or as neoadjuvant treatment for patients with locally advanced, inflammatory, or early stage breast cancer as part of a complete treatment regimen for early breast cancer.
Add to wishlist
Select options
Quick view
Compare

Portrazza (necitumumab)

£7,241.93
Portrazza (necitumumab) is a medication used for the treatment of metastatic squamous non-small cell lung cancer. This medicine has been approved in The US, Canda and Europe. We can get you the US FDA approved stock.
Add to wishlist
Select options
Quick view
Compare

Rubraca (rucaparib)

£1,421.44 – £2,377.32
Rubraca (rucaparib) is a medication used for the treatment of ovarian, fallopian tube and primary peritoneal cancer.
Add to wishlist
Select options
Quick view
Compare

Rydapt (midostaurin)

£12,500.00
Rydapt (midostaurin) is a medication used for the treatment of patients with newly diagnosed acute myeloid leukemia (AML), aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).
Add to wishlist
Select options
Quick view
Compare

Tagrisso (osimertinib)

£4,858.03
Tagrisso (osimertinib) is a medicine for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with a T790M mutation in the epidermal growth factor receptor (EGFR) gene.
Add to wishlist
Select options
Quick view
Compare

Tecentriq (Atezolizumab)

£4,452.90
Tecentriq (atezolizumab) is a medication used for the treatment of locally advanced or metastatic urothelial carcinoma, for the treatment of metastatic non-small cell lung cancer (NSCLC), and for the treatment of advanced triple negative breast cancer (TNBC).
Add to wishlist
Select options
Quick view
Compare

Zejula (niraparib)

£3,086.42 – £4,093.50

Zejula (niraparib) is a medication used for the treatment of recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.

For this product the estimated delivery time is usually between 10 and 20 working days.

Add to wishlist
Select options
Quick view